News from Zyme and the companies we work with.
Welbeck Health Partners Adopts OMED Health’s Home-Based SIBO Testing Pathway Across Its Network
Patients complete SIBO breath testing at home, with diagnosis provided by an in-house OMED Health GI doctor and results returned to Welbeck's clinicians via an online portal Home-based pathway widens [...]
Tecan accelerates Data-Driven Lab journey with Agentic AI developments powered by NVIDIA
Männedorf, Switzerland, June 24, 2026: Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics [...]
FairJourney Bio and AbTherx Partner to Offer Fully Integrated Antibody Discovery
FairJourney Bio brings AbTherx’s Atlas transgenic mouse technologies in-house, enabling partner programmes to run from immunisation to a developability-assessed lead in one continuous workflow Partnership announced at BIO International Convention [...]
TRIMTECH Therapeutics brings total seed round to $47M with additional investment of $14M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio
Johnson & Johnson’s corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”), and BGF join existing investors Cambridge Innovation Capital, DDF, M Ventures, Pfizer Ventures, Eli Lilly [...]
Pheno Therapeutics granted FDA IND clearance for lead multiple sclerosis therapeutic candidate PTD802
US FDA clearance enables first-in-human study of PTD802, a selective GPR17 antagonist Small molecule therapeutic designed to promote remyelination in neurological diseases such as multiple sclerosis Milestone supports Pheno Therapeutics’ [...]
Broken String Biosciences appoints Bruce Eaton PhD as Chairman of the Board
Strengthens Board with experienced industry executive, specializing in strategic planning, organizational leadership and commercial execution Cambridge, UK, 16 June 2026 – Broken String Biosciences, a biotechnology company enabling gene editing [...]
Laverock Therapeutics reports key oncology research milestones
London, UK, 10 June 2026: Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced key in-vivo functional milestones across its [...]
PhoreMost announces lead oncology programme and appoints Chief Medical Officer to support clinical entry
Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1 Comprehensive preclinical data package demonstrates differentiating oral activity and CNS penetration, unlocking treatment of primary and secondary brain cancers [...]
Bio-Rad Receives MicroVal Validation for EZ-CheckTM Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits
Methods Certified by MicroVal for Detection of Listeria spp. and Listeria monocytogenes in Food and Environmental Samples HERCULES, Calif. June 02, 2026 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), [...]
Diagnostics start-up LotusDx establishes R&D laboratory at ONE BioHub to advance at-home STI testing
Dedicated R&D space to accelerate development of at-home testing to provide discreet, simple and fast solutions for sexually transmitted infections ONE BioHub’s location and connectivity will facilitate ongoing clinical engagement [...]
Laverock Therapeutics awarded in excess of £2.2M through two innovation grants to support AI-powered platform development and to expand therapeutic programmes outside of oncology
Grants totalling in excess of £2.2M awarded from two industry leading innovation funds The new grants will support the development of Laverock’s single-cell and AI powered gene-control platform, alongside pipeline [...]
Combat Medical highlights patient impact of HIVEC HEAT trial at the American Urological Association Annual Meeting
MHRA-approved phase 3 study is investigating intravesical delivery of hyperthermic chemotherapy in bladder-sparing treatment of patients with non-muscle invasive bladder cancer Study being conducted across 25 sites in the UK [...]
